Terms: = Endocrine gland cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Staging
11 results:
1. Relationship between Trace Elements and Matrix Metalloproteinases 2 and 9 and their Tissue Inhibitors in Medullary Thyroid Carcinoma.
Vázquez-Lorente H; Dundjerović DM; Tatić SB; Rodríguez-Menéndez S; González-Iglesias H; Gomes CM; Paunović IR; Dragutinović VV
Biol Trace Elem Res; 2023 Jul; 201(7):3225-3232. PubMed ID: 36156766
[TBL] [Abstract] [Full Text] [Related]
2. A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients.
Prokopchuk O; Hermann CD; Schoeps B; Nitsche U; Prokopchuk OL; Knolle P; Friess H; Martignoni ME; Krüger A
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):378-392. PubMed ID: 33590974
[TBL] [Abstract] [Full Text] [Related]
3. A comprehensive validation of the novel 8th edition of American Joint Committee on cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms.
Yang M; Zeng L; Yao WQ; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
Medicine (Baltimore); 2020 Nov; 99(46):e22291. PubMed ID: 33181635
[TBL] [Abstract] [Full Text] [Related]
4. Novel scoring system for recurrence risk classification of surgically resected G1/2 pancreatic neuroendocrine tumors - Retrospective cohort study.
Zou S; Jiang Y; Wang W; Zhan Q; Deng X; Shen B
Int J Surg; 2020 Feb; 74():86-91. PubMed ID: 31926324
[TBL] [Abstract] [Full Text] [Related]
5. Identification of key genes and miRNAs markers of papillary thyroid cancer.
Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
[TBL] [Abstract] [Full Text] [Related]
6. The estimation of metaloproteinases and their inhibitors blood levels in patients with pancreatic tumors.
Śmigielski J; Piskorz Ł; Talar-Wojnarowska R; Malecka-Panas E; Jabłoński S; Brocki M
World J Surg Oncol; 2013 Jun; 11():137. PubMed ID: 23768069
[TBL] [Abstract] [Full Text] [Related]
7. A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.
Ellison TA; Wolfgang CL; Shi C; Cameron JL; Murakami P; Mun LJ; Singhi AD; Cornish TC; Olino K; Meriden Z; Choti M; Diaz LA; Pawlik TM; Schulick RD; Hruban RH; Edil BH
Ann Surg; 2014 Feb; 259(2):204-12. PubMed ID: 23673766
[TBL] [Abstract] [Full Text] [Related]
8. Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters.
Macášek J; Vecka M; Žák A; Urbánek M; Krechler T; Petruželka L; Staňková B; Zeman M
Nutr Cancer; 2012; 64(7):946-55. PubMed ID: 23061902
[TBL] [Abstract] [Full Text] [Related]
9. [Progress of clinical pathology and application of PET-CT on thyroid carcinoma].
Gao M; Li XL; Yu Y; Sun BC; Li SL; Xu WG
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Jun; 41(6):419-24. PubMed ID: 16927796
[TBL] [Abstract] [Full Text] [Related]
10. Concentration of metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in the serum of patients with benign and malignant thyroid tumours treated surgically.
Pasieka Z; Stepien H; Czyz W; Pomorski L; Kuzdak K
Endocr Regul; 2004 Jun; 38(2):57-63. PubMed ID: 15497929
[TBL] [Abstract] [Full Text] [Related]
11. Laparoscopic staging of pancreatic tumors induces increased invasive capacity in vitro.
Ridgway PF; Ziprin P; Jones TL; Paraskeva PA; Peck DH; Darzl AW
Surg Endosc; 2003 Feb; 17(2):306-10. PubMed ID: 12399839
[TBL] [Abstract] [Full Text] [Related]
